O	0	11	Association
O	12	19	between
B-intervention	20	29	allergies
I-intervention	29	30	,
I-intervention	31	37	asthma
O	37	38	,
O	39	42	and
O	43	49	breast
O	50	56	cancer
O	57	61	risk
O	62	67	among
O	68	73	women
O	74	76	in
B-location	77	84	Ontario
I-location	84	85	,
I-location	86	92	Canada
O	92	93	.

O	94	96	To
O	97	108	investigate
O	109	112	the
O	113	124	association
O	125	132	between
O	133	142	allergies
O	142	143	,
O	144	150	asthma
O	150	151	,
O	152	155	and
O	156	162	breast
O	163	169	cancer
O	170	174	risk
O	175	177	in
O	178	179	a
O	180	185	large
O	185	186	,
O	187	197	population
O	197	198	-
O	198	203	based
O	204	208	case
O	208	209	-
O	209	216	control
O	217	222	study
O	222	223	.

O	224	230	Breast
O	231	237	cancer
O	238	243	cases
O	244	245	(
O	245	246	n
O	247	248	=
B-intervention-participants	249	250	3
I-intervention-participants	250	251	,
I-intervention-participants	251	254	101
O	254	255	)
O	256	260	were
O	261	271	identified
O	272	277	using
O	278	281	the
O	282	289	Ontario
O	290	296	Cancer
O	297	305	Registry
O	306	309	and
O	310	320	population
B-control	321	329	controls
O	330	331	(
O	331	332	n
O	333	334	=
B-control-participants	335	336	3
I-control-participants	336	337	,
I-control-participants	337	340	471
O	340	341	)
O	342	349	through
O	350	356	random
O	357	362	digit
O	363	370	dialing
O	370	371	.

O	372	376	Self
O	376	377	-
O	377	385	reported
O	386	395	histories
O	396	398	of
O	399	408	allergies
O	408	409	,
O	410	413	hay
O	414	419	fever
O	419	420	,
O	421	424	and
O	425	431	asthma
O	432	436	were
O	437	446	collected
O	447	449	by
O	450	463	questionnaire
O	463	464	.

O	465	473	Logistic
O	474	484	regression
O	485	488	was
O	489	493	used
O	494	496	to
O	497	503	assess
O	504	516	associations
O	517	524	between
O	525	531	breast
O	532	538	cancer
O	539	543	risk
O	544	547	and
O	548	555	history
O	556	558	of
O	559	566	allergy
O	566	567	/
O	567	570	hay
O	571	576	fever
O	577	580	and
O	581	587	asthma
O	587	588	,
O	589	593	with
O	594	596	16
O	597	605	possible
O	606	617	confounders
O	618	626	examined
O	626	627	.

O	628	636	Analyses
O	637	641	were
O	642	652	stratified
O	653	655	by
O	656	666	menopausal
O	667	673	status
O	673	674	.

O	675	676	A
O	677	684	history
O	685	687	of
O	688	697	allergies
O	698	700	or
O	701	704	hay
O	705	710	fever
O	711	714	was
O	715	725	associated
O	726	730	with
O	731	732	a
O	733	738	small
O	739	748	reduction
O	749	751	in
B-outcome	752	758	breast
I-outcome	759	765	cancer
I-outcome	766	770	risk
O	771	772	[
O	772	775	age
O	775	776	-
O	776	784	adjusted
O	785	789	odds
O	790	795	ratio
O	796	797	(
O	797	800	AOR
O	800	801	)
O	802	803	=
O	804	805	0
O	805	806	.
O	806	808	86
O	808	809	,
O	810	812	95
O	813	814	%
O	815	825	confidence
O	826	834	interval
O	835	836	(
O	836	838	CI
O	838	839	)
O	840	841	0
O	841	842	.
O	842	844	77
O	844	845	-
O	845	846	0
O	846	847	.
O	847	849	96
O	849	850	]
O	851	854	and
O	855	858	did
O	859	862	not
O	863	869	differ
O	870	872	by
O	873	883	menopausal
O	884	890	status
O	890	891	.

O	892	898	Asthma
O	899	902	was
O	903	906	not
O	907	917	associated
O	918	922	with
B-outcome	923	929	breast
I-outcome	930	936	cancer
I-outcome	937	941	risk
I-outcome	942	949	overall
O	949	950	;
O	951	958	however
O	958	959	,
O	960	965	among
O	966	979	premenopausal
O	980	985	women
O	985	986	,
O	987	993	asthma
O	994	997	was
O	998	1008	associated
O	1009	1013	with
O	1014	1015	a
O	1016	1023	reduced
B-outcome	1024	1028	risk
I-outcome	1029	1031	of
I-outcome	1032	1038	breast
I-outcome	1039	1045	cancer
O	1046	1047	(
O	1047	1050	AOR
O	1051	1052	=
O	1053	1054	0
O	1054	1055	.
O	1055	1057	72
O	1057	1058	,
O	1059	1061	95
O	1062	1063	%
O	1064	1066	CI
O	1067	1068	0
O	1068	1069	.
O	1069	1071	54
O	1071	1072	-
O	1072	1073	0
O	1073	1074	.
O	1074	1076	97
O	1076	1077	)
O	1077	1078	.

O	1079	1080	A
O	1081	1088	history
O	1089	1091	of
O	1092	1101	allergies
O	1102	1105	may
O	1106	1108	be
O	1109	1119	associated
O	1120	1124	with
O	1125	1126	a
O	1127	1133	modest
O	1134	1143	reduction
O	1144	1146	in
B-outcome	1147	1153	breast
I-outcome	1154	1160	cancer
I-outcome	1161	1165	risk
O	1165	1166	.

O	1167	1173	Asthma
O	1174	1178	does
O	1179	1182	not
O	1183	1189	appear
O	1190	1192	to
O	1193	1195	be
O	1196	1206	associated
O	1207	1211	with
O	1212	1218	breast
O	1219	1225	cancer
O	1226	1230	risk
O	1231	1238	overall
O	1238	1239	;
O	1240	1247	however
O	1247	1248	,
O	1249	1255	asthma
O	1256	1259	may
O	1260	1262	be
O	1263	1273	associated
O	1274	1278	with
O	1279	1286	reduced
O	1287	1293	breast
O	1294	1300	cancer
O	1301	1305	risk
O	1306	1311	among
O	1312	1325	premenopausal
O	1326	1331	women
O	1331	1332	.
